NO20002176L - Diagnostikk og terapi av kronisk obstruktiv luftveissykdom - Google Patents

Diagnostikk og terapi av kronisk obstruktiv luftveissykdom

Info

Publication number
NO20002176L
NO20002176L NO20002176A NO20002176A NO20002176L NO 20002176 L NO20002176 L NO 20002176L NO 20002176 A NO20002176 A NO 20002176A NO 20002176 A NO20002176 A NO 20002176A NO 20002176 L NO20002176 L NO 20002176L
Authority
NO
Norway
Prior art keywords
chronic obstructive
diagnosis
therapy
obstructive airway
airway disease
Prior art date
Application number
NO20002176A
Other languages
English (en)
Other versions
NO20002176D0 (no
Inventor
Gordon W Duff
Marco Giovine
Peter J Barnes
Simon Lim
Original Assignee
Interleukin Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9723553.5A external-priority patent/GB9723553D0/en
Application filed by Interleukin Genetics Inc filed Critical Interleukin Genetics Inc
Publication of NO20002176D0 publication Critical patent/NO20002176D0/no
Publication of NO20002176L publication Critical patent/NO20002176L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/172Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Metoder og sett for detektering av polymorfisme som indikerer et individs mottakelighet for utvikling av en kronisk obstruktiv luftveissykdom samt relativ alvorlighetsgrad av sykdommen er beskrevet.
NO20002176A 1997-11-07 2000-04-27 Diagnostikk og terapi av kronisk obstruktiv luftveissykdom NO20002176L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9723553.5A GB9723553D0 (en) 1997-11-07 1997-11-07 Prediction of the risk of chronic obstructive airway disease
US09/005,923 US6140047A (en) 1997-11-07 1998-01-12 Method and kit for predicting susceptibility to asthma
PCT/US1998/023721 WO1999024615A2 (en) 1997-11-07 1998-11-09 Diagnostics and therapeutics for chronic obstructive airway disease

Publications (2)

Publication Number Publication Date
NO20002176D0 NO20002176D0 (no) 2000-04-27
NO20002176L true NO20002176L (no) 2000-07-05

Family

ID=26312564

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002176A NO20002176L (no) 1997-11-07 2000-04-27 Diagnostikk og terapi av kronisk obstruktiv luftveissykdom

Country Status (13)

Country Link
EP (1) EP1029079B1 (no)
JP (1) JP2001522586A (no)
AT (1) ATE383438T1 (no)
AU (1) AU760856B2 (no)
BR (1) BR9813950A (no)
CA (1) CA2308570A1 (no)
ES (1) ES2297900T3 (no)
HU (1) HUP0301197A2 (no)
IL (1) IL135957A0 (no)
NO (1) NO20002176L (no)
PL (1) PL340624A1 (no)
TR (1) TR200001263T2 (no)
WO (1) WO1999024615A2 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6251598B1 (en) * 1998-10-30 2001-06-26 Interleukin Genetics, Inc. Methods for diagnosing sepsis
CA2367294A1 (en) * 1999-04-02 2000-10-12 Interleukin Genetics, Inc. Prediction of risk of interstitial lung disease
AU7706000A (en) * 1999-09-22 2001-04-24 Genaissance Pharmaceuticals, Inc. Drug target isogenes: polymorphisms in the interleukin-1 beta gene
WO2002000933A2 (en) * 2000-06-23 2002-01-03 Interleukin Genetics, Inc. Screening assays for identifying modulators of the inflammatory or immune responses
WO2005019259A2 (en) * 2003-08-25 2005-03-03 Compugen Ltd. Variants of interleukin-1 receptor antagonist: compositions and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995001997A1 (en) * 1993-07-09 1995-01-19 Smithkline Beecham Corporation RECOMBINANT AND HUMANIZED IL-1β ANTIBODIES FOR TREATMENT OF IL-1 MEDIATED INFLAMMATORY DISORDERS IN MAN
US5674483A (en) * 1995-01-31 1997-10-07 National Jewish Medical And Research Center Treatment for diseases involving inflammation
US5686246A (en) * 1995-08-03 1997-11-11 Kornman; Kenneth S. Detecting genetic predisposition to periodontal disease
GB9711040D0 (en) * 1997-05-29 1997-07-23 Duff Gordon W Prediction of inflammatory disease

Also Published As

Publication number Publication date
JP2001522586A (ja) 2001-11-20
IL135957A0 (en) 2001-05-20
TR200001263T2 (tr) 2000-12-21
WO1999024615A3 (en) 1999-09-16
CA2308570A1 (en) 1999-05-20
PL340624A1 (en) 2001-02-12
ES2297900T3 (es) 2008-05-01
AU1386399A (en) 1999-05-31
HUP0301197A2 (hu) 2003-07-28
BR9813950A (pt) 2000-09-26
EP1029079A2 (en) 2000-08-23
ATE383438T1 (de) 2008-01-15
AU760856B2 (en) 2003-05-22
WO1999024615A2 (en) 1999-05-20
NO20002176D0 (no) 2000-04-27
EP1029079B1 (en) 2008-01-09

Similar Documents

Publication Publication Date Title
DE69812169D1 (de) Mikropartikel und ihre therapeutische oder diagnostische verwendung
CY1112845T1 (el) Παραγωγα της 1-δεοξυ-γαλακτονογιριμυκινης και η χρηση τους στη θεραπεια αθροιστικων λυσοσωμικων ασθενειων μεσω ενισχυσης της λυσοσωμικης α-γαλακτοσιδασης α
DE59611341D1 (de) Verwendung von saccharid-konjugaten
DE69007732T2 (de) Befestigungsvorrichtung für Computerperipherien.
IT1303245B1 (it) Apparecchio per facilitare l'installazione e la verifica del softwareper un sistema di computer prodotto su ordinazione.
PT1333887E (pt) Metodo de tratamento de desordens musculares
KR970702736A (ko) 비강용 투약기(Medicine Administering Device for Nasal Cavities)
FI93854B (fi) Valettavia elastomeerisia paineherkkiä liimoja
NO20010882D0 (no) Terapier for behandling av lungesykdommer
IT1303246B1 (it) Procedimento per l'installazione e/o la verifica del software per unsistema di computer prodotto su ordinazione, e sistema di computer per
AU6416198A (en) Diagnostic means useful for predictive assessment of human hepatocellular carc inoma disease (hcc), as well as diagnostic methods using the same
NO20011409L (no) Farmasöytiske midler for behandling av Parkinsonssykdom, ADHD og mikroadenomer
NO995245L (no) Anvendelse av tetrahydropyridinderivater for fremstilling av medisiner for å behandle sykdommer som bevirker demyelinisering
BR9607544A (pt) Fluximetro de massa com efeito coriolos que usa rotores concêntricos
NO20002176L (no) Diagnostikk og terapi av kronisk obstruktiv luftveissykdom
EP0787494A4 (en) MEDICINE FOR DISEASES CAUSED BY INFECTIONS WITH HELICOBACTER
FR2735031B1 (fr) Appareil d'anesthesie loco-regionale.
DE69432561D1 (de) Diagnose mentaler störungen
SE9502524D0 (sv) Förfarande för att underlätta diagnostisering av närvaro av destruktiva dataprogram
KR970025161U (ko) 컴퓨터의 본체의 모니터 연결 구조
KR970014193U (ko) 체결용 탄성핀
IT1302612B1 (it) Procedimento per la riproduzione di errori di calcolo nella bandautile di un segnale generato con trasformata di fourier,
ITRM930026V0 (it) Supporto universale per lo sviluppo di modelli di arcate dentarie.
IE782353L (en) Ethyl 2-aryl allophanates, medicaments
KR970023107U (ko) 파워트레인도킹용 기준핀을 갖는 서브프레임

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application